Three interventions and 2 comparators were included in this assessment. Actim Partus is a CE‑marked qualitative immunochromatographic point-of-care test designed to detect phosphorylated IGFBP‑1 ...
Biomarker tests (PartoSure, Actim Partus and the Rapid fetal fibronectin [fFN] 10Q Cassette Kit) are intended for use with other clinical information to assess the risk of preterm birth in women with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback